Pharmafile Logo
Pharmafocus logo
Advanced Search

oxford biotech

Showing 1 posts of 1 posts found.

ImmTAC deal for Immunocore

June 27, 2013
Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech

Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024